ArticleJournal of cellular and molecular medicine2026
Single-Cell Characterization of Terminal States and State-Specific Transcriptional Regulatory Networks in Hepatocellular Carcinoma.
Article in Journal of cellular and molecular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Hepatocellular carcinoma (HCC) exhibits pronounced cellular heterogeneity and dynamic state transitions during tumour progression, yet the emergence of tumour cell states along fate trajectories and their transcriptional regulation remain unclear. Here, we established an integrated framework linking cell fate dynamics with transcriptional regulatory networks using publicly available single-cell RNA sequencing data. Malignant cells were identified by inferred copy number variation, followed by CellRank-based fate inference and SCENIC-based regulatory network reconstruction. We identified three terminal HCC cell states-immune-activated, metabolic, and proliferative hepatocytes-forming a differentiation continuum from stem-like to more mature phenotypes. Each state was governed by a distinct regulatory network with specific core regulators, including IRF3, PPARA, and JUN. Integration with TCGA-LIHC bulk transcriptomic and clinical data revealed that a proliferative state-derived transcriptional signature was associated with poorer overall survival. Together, our study provides a mechanistic framework linking tumour cell fate trajectories, regulatory heterogeneity and clinical outcomes in HCC.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.